Oncology · Precision Cancer Testing

4-Power Biomarker Test
PacBio HiFi Long-read Whole Genome

Next-generation long-read whole genome sequencing integrating genomic and epigenomic biomarkers in one assay.

Fresh tumor + matched blood
Sample Type
Tumor ± normal
Samples
~14 working days
Turnaround Time

4-Power Biomarker Test at Nucleome Informatics

PacBio HiFi Long-read Whole Genome

Why this Test Matters

Precision oncology depends on identifying clinically actionable genomic alterations. This assay helps clinicians select targeted therapies, evaluate immunotherapy eligibility, identify prognostic biomarkers, detect resistance mechanisms, and match patients to suitable clinical trials while minimizing sequential testing.

Who Should Consider this Test

  • Relapsed cancer
  • Panel/WES negative cases
  • Complex genomes

Applicable Cancer Types

Most solid tumors and Liquid cancers AML/CML

What the test covers and delivers

What is Covered

  • SNVs
  • InDels
  • SVs
  • CNVs
  • CpG methylation
  • MSI
  • TMB
  • Tumor purity
  • Mutational signatures

Clinical Utility​

  • Treatment selection
  • Prognostic and predictive biomarkers
  • Clinical trial matching
  • Identification of actionable alterations
  • Comprehensive clinical interpretation

Technology

PacBio HiFi Long-read WGS

Test specifications

ParameterDetails
Sample TypeFresh tumor + matched blood
SamplesTumor ± normal
Turnaround Time~14 working days
Report IncludesVariant interpretation, therapy associations, clinically actionable biomarkers
QualityHigh-depth NGS with rigorous QC
Talk to our team. Email info@nucleomeinfo.com or call +91 40 40114169 to discuss sample requirements and turnaround for 4-Power Biomarker Test.